(62 days)
The ORS Visual is a software-based Picture Archiving and Communication System (PACS) for the display and 3D visualization of medical image data. It provides for communication, storage, reformatting, rendering, and analysis of medical image data from various sources including CT and MRI.
The ORS Visual software is intended for use as a diagnostic, review, and analysis tool by trained professionals such as physicians, technologists, and nurses. When interpreted by a trained physician, reviewed images are intended to be used to aid in diagnosis. It is the users' responsibility to ensure that the software is installed on appropriate hardware and that image quality is sufficient for the clinical application. Object Research Systems (ORS) recommends that users of the ORS Visual software consult the appropriate American College of Radiology (ACR) guidelines for the clinical setting and pathology being studied.
Mammographic and compressed images are not supported for viewing.
The software is not intended to replace the skill and judgment of a qualified medical professional. Users should be appropriately trained in the software's functions, capabilities and limitations. Users should be aware that certain views, and on the make use of interpolated data. This is data that is created by the software based on the original data set. Interpolated data may give the appearance of healthy tissue in situations where pathological conditions or limited original data set resolution may be present.
ORS Visual software must be installed on a suitable commercial computer platform. It is the users' responsibility to ensure that the hardware and display configurations are consistent with the clinical applications.
Typical users of ORS Visual are trained medical professionals, including but not limited to radiologists, clinicians, technologists, and others.
The ORS Visual is a software-based Picture Archiving and Communication System (PACS) for the display and 3D visualization of medical image data. It provides for communication, storage, reformatting, rendering, and analysis of medical image data from various sources including CT and MRI.
This a 510(k) premarket notification for ORS Visual, a Picture Archiving and Communication System (PACS). No clinical study was performed to justify substantial equivalence. Since this is for a PACS device, the FDA often does not require specific clinical study data as they are not typically diagnostic devices themselves but rather display and communication systems for medical images. The substantial equivalence is therefore claimed using legally marketed predicate devices, as stated in the letter.
Here's a breakdown of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance:
Not applicable in this context. The document does not describe performance criteria based on a clinical study for the ORS Visual device. Its substantial equivalence is based on its similarity to previously cleared PACS devices.
2. Sample Size Used for the Test Set and Data Provenance:
Not applicable, as no specific test set or clinical study for performance was conducted or reported in this 510(k) submission.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:
Not applicable, as no specific test set or ground truth establishment process is described for performance evaluation.
4. Adjudication Method for the Test Set:
Not applicable, as no specific test set or adjudication process is described for performance evaluation.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
No. An MRMC comparative effectiveness study was not performed or reported in this document. The device is a PACS system for displaying and visualizing medical images, not a diagnostic AI algorithm that would typically undergo such a study to quantify human reader improvement.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study:
Not applicable. The ORS Visual is described as a "software-based Picture Archiving and Communication System (PACS)" intended for use "as a diagnostic, review, and analysis tool by trained professionals." It is explicitly stated that "The software is not intended to replace the skill and judgment of a qualified medical professional." This indicates it's a human-in-the-loop system, and a standalone algorithm-only performance study would not be relevant for this type of device.
7. Type of Ground Truth Used:
Not applicable. There is no mention of a ground truth being established for the performance evaluation of the ORS Visual device.
8. Sample Size for the Training Set:
Not applicable. As no independent clinical study was performed for the performance evaluation of the ORS Visual, there is no mention of a training set or its size.
9. How the Ground Truth for the Training Set Was Established:
Not applicable, as there is no mention of a training set or ground truth establishment for it.
Summary based on the document:
The provided document is a 510(k) clearance letter for a PACS device (ORS Visual). It highlights that the device is substantially equivalent to legally marketed predicate devices. The review process for such devices often focuses on functional equivalence, technical specifications, and safety, rather than extensive clinical performance studies with acceptance criteria, ground truth, and expert adjudication, which are more common for diagnostic algorithms. The document explicitly states that the device is "not intended to replace the skill and judgment of a qualified medical professional," reinforcing its role as a tool rather than an autonomous diagnostic system.
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized human figure embracing a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES" is arranged around the top half of the circle.
APR 2 9 2010
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. John Howlett Head of BSI Medical Device Notified Body BSI Group, Product Services British Standards Instution, Maylands Avenue Hemel Hempstead, Herts HP2 4SQ UNITED KINGDOM
Re: K100335
Trade/Device Name: ORS Visual Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: March 22, 2010 Received: March 25, 2010
Dear Mr. Howlett:
This letter corrects our substantially equivalent letter of April 8, 2010.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
{1}------------------------------------------------
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Donald J. Trump
Donald J. St. Pierre Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Notification (21 CFR 807.90(e))
4. INDICATIONS FOR USE
510(k) Number: Unknown
Device Name: ORS Visual
Indications for Use:
The ORS Visual is a software-based Picture Archiving and Communication System (PACS) The ORS Visual is a solware-based i leture for the display and 3D visualization of medical image data. It provides for communication, storage, reformatting, rendering, and medical limage data. It provides for bonnianious; sources including CT and MRI.
The ORS Visual software is intended for use as a diagnostic, review, and analysis tool by trained professionals such as physicians, technologists, and nurses. When interpreted by a trained professionals such as physicians, technologicio, and for the users and that image trained physician, reviewed that the software is installed on appropriate hardware and that image
responsibility to ensure that the software is installed on appropriate hardw responsibility to ensure that the Soltware is installed on Species (ORS) recommends quality is sufficalle for the cifilical application: Object Noorican College of Radiology
that users of the ORS Visual software consult the appropriate American College of Ra that users of the ONO visual sonthal setting and pathology being studied.
Mammographic and compressed images are not supported for viewing.
The software is not intended to replace the skill and judgment of a qualified medical The solware is not intended to Teplace who have been a supropriately trained in the software's functions, capabilities and limitations. Users should be aware that certain views, and on the make use of interpolated data. This is data that is created by the software based on the original data set. Interpolated data may give the appearance of healthy tissue in situations
original data set. Interpolated data may give the appearce of healthy the procent original data set. Interpolated "data may give the applical resolution may be present.
ORS Visual software must be installed on a suitable commercial computer platforn. It is the ORS Visual soltware must be mstalled on a sultable ochinerali componitions are consistent with the clinical applications.
Typical users of ORS Visual are trained medical professionals, including but not limited to radiologists, clinicians, technologists, and others.
Prescription Use _ X (Part 21 CFR 801 Subpart D)
510K
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Doylog Braluation (ODE) CLU C
Robert F. Beecher
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety
K100335
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).